◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Dalmia Bharat Limited (DALBHARAT) Revenue 2023–TTM

Name: Dalmia Bharat Limited (DALBHARAT) revenue history 2023-TTM
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

DATA UPDATED 2026-11-01

Dalmia Bharat Limited annual revenue for fiscal TTM was ₹152.0 billion, an increase of 5.1% from ₹144.7 billion in fiscal 2026. All figures are reported results from public filings — no estimates or projections.

DALBHARAT Annual Revenue

Revenue (annual)	TTM → 2026-09-30	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Total Revenue	₹152.0B	₹144.7B	₹135.7B	₹143.3B	₹132.4B

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

DALBHARAT Quarterly Revenue

Revenue (quarterly)	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Total Revenue	₹35.6B	₹38.9B	₹42.5B	₹35.1B	—	₹36.4B

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Revenue at Comparable Companies

AMBUJACEM Revenue — Ambuja Cements Limited
SHREECEM Revenue — Shree Cement Limited
5233 Revenue — Taiheiyo Cement Corporation
JKCEMENT Revenue — J.K. Cement Limited
5232 Revenue — Sumitomo Osaka Cement Co., Ltd.

More DALBHARAT metrics: Gross Profit · Operating Income · Net Income · EPS · Free Cash Flow

All DALBHARAT financial statements → Interactive DALBHARAT charts →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.